The Soft Tissue Biologics Market is benefiting from the increasing use of biological materials in tissue repair and surgical reconstruction. WiseGuyReports estimates that the market will grow from USD 4.36 billion in 2024 to USD 10.6 billion by 2032, with an 11.75% CAGR. Chronic wounds, musculoskeletal disorders, and demand for regenerative therapies are creating sustained opportunities....